which glp 1 drugs are approved for obesity Indications GLP-1/GIP RA Summary Sheet and Beyond! The GLP-1 Access Gap: Mapping

Clin Res Cardiol

What I find clinically interesting is how gentle these drugs are

[DOI] [PMC free article] [PubMed] [Google Scholar] 170.Jall S., Sachs S., Clemmensen C., Finan B., Neff F., DiMarchi R.D., Tschp M.H., Mller T.D., Hofmann S.M

Policymakers should also consider the social benefits of GLP-1-RAs, such as reducing health inequities and enhancing the overall population health

Ultimately, you need to work with your doctor to answer that question, but your dietitian can help you talk through the pros and cons

Additionally, the development of oral formulations is expected to broaden the market reach, making these drugs more accessible to patients who prefer non-injection methods, thus driving market growth in the GCC